Power Analytics Global Acquired by Drugs Made In America Acquisition | Technology M&A Deal

Drugs Made In America Acquisition has acquired Power Analytics Global, a enterprise software business in Delaware, for $1,000,000,000. Drugs Made In America Acquisition acquisitions target Power Analytics Global’s AI and analytics capabilities, supporting data-driven decisioning for enterprise customers. The enterprise software acquisition fits technology M&A priorities for technology deals DE, with Drugs Made In America Acquisition acquisitions aimed at scaling analytics products from Delaware. The merger acquisition is announced and structured as a private equity acquisition by a SPAC-backed buyer, with expected PIPE financing and stockholder approval as key closing conditions.